Generate a tailored SOP for Dr. Shaojun Zhu. Improve your application with a focused, well-structured draft.
Shaojun Zhu is an Associate Professor in the Department of Molecular and Medical Pharmacology at the University of California, Los Angeles (UCLA). His academic career includes education at Nankai University in China, where he received Bachelor's and Master's degrees in Biochemistry and Molecular Biology, and a Master's degree in Regulatory Science from the University of Southern California. His research interests focus on regulatory science within the field of radiopharmaceuticals, encompassing the development of diagnostics and therapeutics. Mr. Zhu's work involves creating regulatory strategies and frameworks, assessing regulatory risks, and planning regulatory pathways for nonclinical safety assessments related to pharmacology and toxicology of radiopharmaceuticals. He oversees critical regulatory interactions with entities such as the Food and Drug Administration (FDA) and the Center for Medicare & Medicaid Services (CMS) related to clinical trial clearances and approvals for radiopharmaceuticals. His efforts have led to successful Investigational Drug Application (IND) clearances and New Drug Application (NDA) approvals, as well as conducting FDA site inspections, demonstrating a significant impact on advancing the development and compliance of radiopharmaceuticals.
University of California, Los Angeles • Los Angeles, CA
Educator and researcher focused on regulatory science and radiopharmaceuticals.
Department of Economics admits primarily for the PhD program.